Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.7 EUR | +1.14% |
|
+0.76% | -10.81% |
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 73% by 2026.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 9.46 for the current year.
- The company is one of the best yield companies with high dividend expectations.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-10.81% | 26.86B | - | ||
+3.97% | 72.47B | B- | ||
+8.05% | 51.15B | B | ||
+6.59% | 50.78B | B+ | ||
+20.47% | 47.4B | B+ | ||
+13.11% | 42.58B | B+ | ||
+22.22% | 38.93B | B | ||
+16.65% | 33.75B | B | ||
-3.67% | 28.35B | B | ||
+30.05% | 27.28B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- GWO Stock
- GWS Stock
- Ratings Great-West Lifeco Inc.